These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33996466)

  • 1. Native mitral valve endocarditis associated with KPC producing
    Tilanus A; Rincon FM; Rivera AM
    IDCases; 2021; 24():e01137. PubMed ID: 33996466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam.
    Iacovelli A; Spaziante M; Al Moghazi S; Giordano A; Ceccarelli G; Venditti M
    Infection; 2018 Oct; 46(5):721-724. PubMed ID: 29926399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.
    Gaibani P; Re MC; Campoli C; Viale PL; Ambretti S
    Clin Microbiol Infect; 2020 Apr; 26(4):516.e1-516.e4. PubMed ID: 31740422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime/avibactam susceptibility by three different susceptibility testing methods in carbapenemase-producing Gram-negative bacteria from Australia.
    Sherry NL; Baines SL; Howden BP
    Int J Antimicrob Agents; 2018 Jul; 52(1):82-85. PubMed ID: 29499316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime/Avibactam for Refractory Bacteremia, Vertebral Diskitis/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC).
    De León-Borrás R; Álvarez-Cardona J; Vidal JA; Guiot HM
    P R Health Sci J; 2018 Jun; 37(2):128-131. PubMed ID: 29905925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Antinori E; Unali I; Bertoncelli A; Mazzariol A
    Clin Microbiol Infect; 2020 Jul; 26(7):946.e1-946.e3. PubMed ID: 32061796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serratia marcescens endocarditis treated with ceftazidime. A case report.
    Berkowitz FE; Colsen P; Raw K
    S Afr Med J; 1983 Jul; 64(3):105-6. PubMed ID: 6346520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Huang Y; Wu T; Perez O; Rana AP; Chen L; Kreiswirth BN; Satlin MJ; Bulman ZP
    Front Microbiol; 2021; 12():618087. PubMed ID: 33763041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment.
    Veillette JJ; Truong J; Forland SC
    Pharmacotherapy; 2016 Nov; 36(11):e172-e177. PubMed ID: 27716983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
    Galani I; Antoniadou A; Karaiskos I; Kontopoulou K; Giamarellou H; Souli M
    Clin Microbiol Infect; 2019 Jun; 25(6):763.e5-763.e8. PubMed ID: 30928562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The β-Lactams Strike Back: Ceftazidime-Avibactam.
    Zasowski EJ; Rybak JM; Rybak MJ
    Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Effect of Ceftazidime-Avibactam with Meropenem against Panresistant, Carbapenemase-Harboring
    Gaudereto JJ; Perdigão Neto LV; Leite GC; Ruedas Martins R; Boas do Prado GV; Rossi F; Guimarães T; Levin AS; Costa SF
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of recurring Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae septic shock episodes due to complicated soft tissue infection using a ceftazidime and avibactam-based regimen: a case report.
    Parruti G; Frattari A; Polilli E; Savini V; Sciacca A; Consorte A; Cibelli DC; Agostinone A; Di Masi F; Pieri A; Cacciatore P; Di Iorio G; Fazii P; Spina T
    J Med Case Rep; 2019 Jan; 13(1):20. PubMed ID: 30665450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity.
    Nelson K; Hemarajata P; Sun D; Rubio-Aparicio D; Tsivkovski R; Yang S; Sebra R; Kasarskis A; Nguyen H; Hanson BM; Leopold S; Weinstock G; Lomovskaya O; Humphries RM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.
    Papadimitriou-Olivgeris M; Bartzavali C; Lambropoulou A; Solomou A; Tsiata E; Anastassiou ED; Fligou F; Marangos M; Spiliopoulou I; Christofidou M
    J Antimicrob Chemother; 2019 Jul; 74(7):2051-2054. PubMed ID: 31002313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections.
    Shields RK; Nguyen MH; Chen L; Press EG; Kreiswirth BN; Clancy CJ
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.